Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pig-Skin gel takes on surgical bleeding in 324-Patient trial

NCT ID NCT07830797

NEW Disease control Sponsor: Medprin Regenerative Medical Technologies Co., Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing an absorbable fluid gelatin made from pig skin to see if it stops bleeding during surgery as well as an existing product called SURGIFLO. The trial enrolls 324 adults scheduled for general, orthopedic, or gynecological operations. Surgeons apply the gelatin to a bleeding site and cover it with moist gauze, then measure how many sites stop bleeding within 5 minutes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an absorbable hemostatic fluid gelatin made from pig skin
What this could lead to
If it works as well as the existing product, surgeons could have another option for controlling bleeding during operations.
What could go wrong
The trial may show the new gelatin is less effective than SURGIFLO, or it may cause reactions in people allergic to pig products. Results from this controlled setting may not apply to all types of surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 324 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Age ≥18 years; * 2\. Scheduled for elective/semi-elective surgery in General Surgery, Orthopedics, or Gynecology; * 3\. Signed informed consent. (Intra-op): 1. Presence of a suitable Target Bleeding Site (TBS). Exclusion Criteria: * 1\. Allergy to porcine gelatin or refusal of porcine-derived products; * 2\. INR\>1.5 or PLT\<100×10⁹/L; * 3\. Severe hepatic/renal dysfunction; * 4\. Pregnancy/lactation; * 5\. Participation in another trial within 30 days; * 6\. Unsuitable per investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Surgical bleeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Surgical bleeding

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.